Showing results (101-110 of 370) with videos related to
Sort By:
Pageof 37
Surgical Neurology|September 11, 2007
Bone health in patients with brain tumorsArnaldo Neves Da Silva, Ailleen Heras-Herzig, David SchiffHematology/Oncology Clinics of North America|October 5, 2021
Central Nervous System Complications Among Oncology PatientsSebastian F Winter, Jasmin Jo, David Schiff, et al.Neuro-Oncology Practice|December 14, 2019
Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomasHaroon Ahmad, Camilo E Fadul, David Schiff, et al.Oncotarget|December 13, 2017
Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastomaYuji Piao, Verlene Henry, Ningyi Tiao, et al.Nature Reviews. Clinical Oncology|August 27, 2009
Neurological adverse effects caused by cytotoxic and targeted therapiesDavid Schiff, Patrick Y Wen, Martin J van den BentExpert Opinion on Biological Therapy|May 15, 2008
Cintredekin besudotox in treatment of malignant gliomaMelike Mut, Jonathan H Sherman, Mark E Shaffrey, et al.Neurosurgery Clinics of North America|March 18, 2004
Intraventricular gliomasAaron S Dumont, Elana Farace, David Schiff, et al.Molecular Cancer Therapeutics|November 9, 2005
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.Neuro-Oncology|August 12, 2021
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?Jasmin Jo, Joseph Donahue, Guneet Sarai, et al.Neuro-Oncology Practice|January 20, 2023
Navigating disability insurance in the American healthcare system for the low-grade glioma patientLalanthica Yogendran, Mark Rudolf, Drew Yeannakis, et al.Pageof 37